course in the ward. day of admission (oct. 21, 2010) patient was placed on npo; vital signs were...
TRANSCRIPT
![Page 1: COURSE IN THE WARD. Day of admission (Oct. 21, 2010) Patient was placed on NPO; vital signs were monitored q1h (including pupillary light reflex) and](https://reader036.vdocument.in/reader036/viewer/2022082818/56649e735503460f94b73a38/html5/thumbnails/1.jpg)
COURSE IN THE WARD
![Page 2: COURSE IN THE WARD. Day of admission (Oct. 21, 2010) Patient was placed on NPO; vital signs were monitored q1h (including pupillary light reflex) and](https://reader036.vdocument.in/reader036/viewer/2022082818/56649e735503460f94b73a38/html5/thumbnails/2.jpg)
Day of admission (Oct. 21, 2010)• Patient was placed on NPO; vital signs were monitored
q1h (including pupillary light reflex) and fluid input and output
• Patient was given IVF D5/MB 500mL to run at 11-12mL/hr
• CBC with platelet revealed anemia with Hgb 106 g/L and Hct 0.32
• Blood chemistry showed low creatinine 0.22 mg/dL and Na of 136 mEq/L; K and total Ca were normal
![Page 3: COURSE IN THE WARD. Day of admission (Oct. 21, 2010) Patient was placed on NPO; vital signs were monitored q1h (including pupillary light reflex) and](https://reader036.vdocument.in/reader036/viewer/2022082818/56649e735503460f94b73a38/html5/thumbnails/3.jpg)
Day of admission (Oct. 21, 2010)• Blood CS was negative for growth
• CSF analysis showed no growth on culture and sensitivity; Gram stain was negative for growth; high CHON and normal sugar levels
The following drugs were given:
• Phenobarbital 85 mg/SIVP over 30 mins (loading dose) was given then 12mg/SIVP over q12h, 12hrs after the loading dose
• Meropenem 120 mg/IV infusion over 30mins q8h (40 mg/kg/dose) • Gentamycin 12 mg/SIVP OD (4mg/kg/day)• Dexamethasone 0.6 mg/SIVP q6h for 2 days only• Diazepam 1.2 mg/SIVP for seizure >5 mins
![Page 4: COURSE IN THE WARD. Day of admission (Oct. 21, 2010) Patient was placed on NPO; vital signs were monitored q1h (including pupillary light reflex) and](https://reader036.vdocument.in/reader036/viewer/2022082818/56649e735503460f94b73a38/html5/thumbnails/4.jpg)
Day of admission (Oct. 21, 2010)
• Referral to Pediatric Neurology (Diagnosis: Seizure disorder, etiology to be determined)
• MRI with contrast showed normal findings
![Page 5: COURSE IN THE WARD. Day of admission (Oct. 21, 2010) Patient was placed on NPO; vital signs were monitored q1h (including pupillary light reflex) and](https://reader036.vdocument.in/reader036/viewer/2022082818/56649e735503460f94b73a38/html5/thumbnails/5.jpg)
1st HD (Oct. 22, 2010)
• Patient had seizures for which phenytoin 65 mg/IV infusion for 30 mins (15.3 mg/kg/dose) was given as loading dose then 11 mg/IV infusion for 30 mins q12h after
![Page 6: COURSE IN THE WARD. Day of admission (Oct. 21, 2010) Patient was placed on NPO; vital signs were monitored q1h (including pupillary light reflex) and](https://reader036.vdocument.in/reader036/viewer/2022082818/56649e735503460f94b73a38/html5/thumbnails/6.jpg)
2nd - 4th HD (Oct. 23-25, 2010)
• No episodes of seizure
![Page 7: COURSE IN THE WARD. Day of admission (Oct. 21, 2010) Patient was placed on NPO; vital signs were monitored q1h (including pupillary light reflex) and](https://reader036.vdocument.in/reader036/viewer/2022082818/56649e735503460f94b73a38/html5/thumbnails/7.jpg)
5th HD (Oct. 26, 2010)
Recurrence of seizure with upward rolling of eyes and stiffening of extremities for which the ff drugs were given:
• IV phenytoin was shifted to oral 125 mg/5mL, 0.5 mL q12h
• Phenobarbital grain ½ 30 mg/tab ½ tab ODHS
MRI showed normal findings
![Page 8: COURSE IN THE WARD. Day of admission (Oct. 21, 2010) Patient was placed on NPO; vital signs were monitored q1h (including pupillary light reflex) and](https://reader036.vdocument.in/reader036/viewer/2022082818/56649e735503460f94b73a38/html5/thumbnails/8.jpg)
5th HD (Oct. 26, 2010)• d/c meropenem and gentamycin after
consumption of open stocks
• Recurrence of seizures almost every hour (1-3 mins/episode)
• O2 per face mask at 51ppm was given
• Phenobarbital 12 mg/SIVP after 12 hrs and phenytoin 11 mg/SIVP q12hrs were given
![Page 9: COURSE IN THE WARD. Day of admission (Oct. 21, 2010) Patient was placed on NPO; vital signs were monitored q1h (including pupillary light reflex) and](https://reader036.vdocument.in/reader036/viewer/2022082818/56649e735503460f94b73a38/html5/thumbnails/9.jpg)
6th HD (Oct. 27, 2010)
• Still with seizure episodes
• Phenobarbital load of 46 mg/SIVP was given and was maintained at 12 mg/SIVP after 12 hrs
• Serum phenobarbital and phenytoin revealed elevated phenobarbital of 31.66 and low phenytoin of 1.20; high-sensitive CRP was normal
![Page 10: COURSE IN THE WARD. Day of admission (Oct. 21, 2010) Patient was placed on NPO; vital signs were monitored q1h (including pupillary light reflex) and](https://reader036.vdocument.in/reader036/viewer/2022082818/56649e735503460f94b73a38/html5/thumbnails/10.jpg)
8th HD (Oct. 29, 2010)
• Phenytoin was given at 8mg/SIVP per infusion and phenobarbital dose was maintained
• Topiramate 25 mg/tab divided into 10 pptabs was given OD
• Pyridoxine 50 mg/tab was also started
• EEG was deferred
![Page 11: COURSE IN THE WARD. Day of admission (Oct. 21, 2010) Patient was placed on NPO; vital signs were monitored q1h (including pupillary light reflex) and](https://reader036.vdocument.in/reader036/viewer/2022082818/56649e735503460f94b73a38/html5/thumbnails/11.jpg)
11th HD (Nov. 1, 2010) • Still with seizure episodes
The ff. medications were given:• Pyridoxine 50 mg/tab BID• Topiramate 25 mg/tab divided to 5 pptabs, 1
pptab BID• Phenytoin 10 mg/SIVP• Phenobarbital 12 mg/SIVP• Diazepam 1.2 mg/SIVP for active seizures• Ketoconazole shampoo 3x/week
![Page 12: COURSE IN THE WARD. Day of admission (Oct. 21, 2010) Patient was placed on NPO; vital signs were monitored q1h (including pupillary light reflex) and](https://reader036.vdocument.in/reader036/viewer/2022082818/56649e735503460f94b73a38/html5/thumbnails/12.jpg)
13th HD (Nov. 3, 2010)
The ff. drugs were given:
• Phenytoin 125 mg/5 mL 0.4 mL q4h• Phenobarbital 30 mg/tab divided into 10
pptabs to be given 4 pptabs q12h on oral form
![Page 13: COURSE IN THE WARD. Day of admission (Oct. 21, 2010) Patient was placed on NPO; vital signs were monitored q1h (including pupillary light reflex) and](https://reader036.vdocument.in/reader036/viewer/2022082818/56649e735503460f94b73a38/html5/thumbnails/13.jpg)
14th HD (Nov. 4, 2010)
• 21 channel EEG was done
The rest of the hospital stay was unremarkable.
![Page 14: COURSE IN THE WARD. Day of admission (Oct. 21, 2010) Patient was placed on NPO; vital signs were monitored q1h (including pupillary light reflex) and](https://reader036.vdocument.in/reader036/viewer/2022082818/56649e735503460f94b73a38/html5/thumbnails/14.jpg)
Date of discharge (Nov. 6, 2010)
Take home medications:• Topiramate 25 mg/tab 1 tab divided into 5
pptabs then give 1 pptab BID• Phenytoin 125 mg/5 mL, 0.4 mL TID• Phenobarbital grain 1 (60 mg/tab) 1 tab
divided into 6 pptabs, 1 pptab q12h• Pyridoxine 50 mg/tab 1 tab AM, 2 tabs PM
(total dose 150 mg)
![Page 15: COURSE IN THE WARD. Day of admission (Oct. 21, 2010) Patient was placed on NPO; vital signs were monitored q1h (including pupillary light reflex) and](https://reader036.vdocument.in/reader036/viewer/2022082818/56649e735503460f94b73a38/html5/thumbnails/15.jpg)
Date of discharge (Nov. 6, 2010)
Special instructions:• To have standby O2 tank at home• Seizure precautions at all times
Follow-up or Transfer Instructions:• Follow-up at Pedia SBC on Nov. 13, 2010, 8AM• Follow-up after 2 wks at Pedia-Neuro OPD on
Nov. 23, 2010 at 2PM (to bring results of EEG)